Hofseth Biocare ASA (HBC) — Capital Reinvestment Ratio
Latest as of December 2024:
1.43x
Hofseth Biocare ASA (HBC) has a Capital Reinvestment Ratio of 1.43x as of December 2024, meaning it reinvests 1% of its operating cash flow (Nkr851.00K) in capital expenditures (Nkr1.22 Million). See HBC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.43x
Capex / Operating Cash Flow
Operating Cash Flow
Nkr851.00K
NOK
Capital Expenditures
Nkr1.22 Million
NOK
Data as of
Dec 2024
Most recent filing
Hofseth Biocare ASA Capital Reinvestment Ratio (2015–2023)
This chart tracks Hofseth Biocare ASA's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Hofseth Biocare ASA (2015–2023)
Year-by-year Capital Reinvestment Ratio for Hofseth Biocare ASA from 2015 to 2023. For live market cap and broader valuation context, see market value of Hofseth Biocare ASA.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.97x | Nkr2.76 Million | Nkr8.19 Million | ▲ +99.7% |
| 2015 | 1.49x | Nkr7.97 Million | Nkr11.84 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow